Related Experiment Videos
A ten-year retrospective study of pink and yellow neonatal hyaline membrane disease
Insights
Yellow staining in neonatal hyaline membrane disease, linked to bilirubin, has increased in premature infants. This finding, observed in autopsies, correlates with longer survival and suggests prior tissue damage, not toxicity.
Area of Science:
- Neonatal Pathology
- Perinatal Medicine
- Bilirubin Metabolism
Background:
- Neonatal hyaline membrane disease (HMD) is a significant cause of respiratory distress in premature infants.
- Yellow staining of pulmonary membranes in HMD, associated with bilirubin, has shown an increasing prevalence.
- The clinical significance and underlying mechanisms of this yellow staining remain areas for investigation.
Purpose of the Study:
- To investigate the changing incidence of yellow bilirubin staining in pulmonary hyaline membranes in neonatal HMD.
- To compare clinical and pathological characteristics of infants with yellow versus eosinophilic HMD.
- To explore the correlation between pulmonary bilirubin staining, kernicterus, and infant survival.
Main Methods:
- Retrospective autopsy study of neonatal cases with hyaline membrane disease.
- Comparison of infants with yellow HMD membranes versus eosinophilic HMD membranes (n=499 vs. n=168).
- Matched cohort analysis comparing infants with yellow and pink HMD membranes for gestational age, birth year, and survival.
Main Results:
- The incidence of yellow HMD membranes increased from 7% in 1970 to 50% in 1980.
- Infants with yellow membranes were more premature, had lower birth weight, and survived longer.
- A strong correlation between kernicterus and pulmonary bilirubin staining emerged in the latter years of the study.
Conclusions:
- The increased prevalence of yellow HMD membranes is associated with improved survival in very premature infants.
- Pulmonary and cerebral bilirubin staining appear to be markers of prolonged survival and prior tissue damage, rather than direct bilirubin toxicity.
- Further research is needed to elucidate the precise mechanisms and implications of bilirubin deposition in the lungs and brain of neonates.
Abstract:
Since it was first described several years ago, yellow bilirubin staining of the pulmonary membranes in neonatal hyaline membrane disease has apparently become more common. In a retrospective study of neonatal autopsy experience, it was found that as more of the premature infants survived longer, yellow hyaline membrane disease was a more frequent finding, increasing from 7% of all newborns having hyaline membrane disease at autopsy in 1970 to 50% in 1980. In comparing 499 cases with eosinophilic hyaline membranes with 168 cases of yellow membranes, newborns with bilirubin staining of the pulmonary membranes were found to be more premature (P less than .02), had smaller autopsy weight (P less than .002), and survived longer (P less than .00001). When multiple clinical parameters were compared between a group of infants with yellow membranes and a group of infants with pink membranes who were matched for gestational age, year of birth, and length of survival, no differences were found between the two groups. No correlation was found between kernicterus and yellow staining of the pulmonary hyaline membranes in the first years of the study, but there was a strong correlation in the last 5 years, coincident with the increase in the rate of yellow hyaline membrane disease found at autopsy. The gross bilirubin staining of the brain was the secondary type of kernicterus, not toxic bilirubin encephalopathy. The observation of bilirubin staining in the lung and in the brain correlates with prolonged survival in some very small premature infants. This does not appear to be a manifestation of bilirubin toxicity, but rather a marker of prior tissue damage.